Satyam Pharma Chem Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-07-2024
- Paid Up Capital ₹ 2.00 Cr
as on 16-07-2024
- Company Age 43 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 46.19 Cr
as on 16-07-2024
- Satisfied Charges ₹ 18.95 Cr
as on 16-07-2024
- Revenue -0.17%
(FY 2023)
- Profit 16.15%
(FY 2023)
- Ebitda 11.96%
(FY 2023)
- Net Worth 15.19%
(FY 2023)
- Total Assets 6.93%
(FY 2023)
About Satyam Pharma Chem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹46.19 Cr. The company has closed loans amounting to ₹18.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Navin Khokhani, Samit Khokhani, Krishnaswamy Iyer, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110MH1981PTC025331
- Company No.
025331
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Oct 1981
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai Central, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Satyam Pharma Chem Private Limited offer?
Satyam Pharma Chem Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Ammonium Compound, Organic and Inorganic Solvents, Carboxylate Esters, Industrial Chemicals & Supplies, Industrial Salts, Metal Oxides, Catalysts.
Who are the key members and board of directors at Satyam Pharma Chem?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Navin Khokhani | Managing Director | 01-Oct-1981 | Current |
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Samit Khokhani | Director | 01-Nov-1995 | Current |
Krishnaswamy Iyer | Director | 23-Sep-2013 | Current |
Rakesh Shah | Director | 12-Jul-2019 | Current |
Financial Performance of Satyam Pharma Chem.
Satyam Pharma Chem Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.17% decrease. The company also saw a substantial improvement in profitability, with a 16.15% increase in profit. The company's net worth Soared by an impressive increase of 15.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Satyam Pharma Chem?
In 2023, Satyam Pharma Chem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 27 Feb 2024 | ₹0.80 M | Open |
Others Creation Date: 30 Oct 2021 | ₹4.00 M | Open |
Standard Chartered Bank Creation Date: 04 Feb 2020 | ₹6.00 Cr | Open |
How Many Employees Work at Satyam Pharma Chem?
Satyam Pharma Chem has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Satyam Pharma Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satyam Pharma Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.